IL6 and neoplasm: Another strategy tested to achieve tumor remission was the inhibition of CD10+ and GPR77+ CAFs by IL-6 and IL-8 antibodies or anti-GPR-77 antibodies in combination with docetaxel in a xenograft model [114].